Cainap, Calin <br/><br/>
Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 2015 
 - 172-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2013.54.3298  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Carcinoma, Hepatocellular--drug therapy<br/>Drug Administration Schedule<br/>Female<br/>Hand-Foot Syndrome--etiology<br/>Humans<br/>Hypertension--chemically induced<br/>Indazoles--administration & dosage<br/>Kaplan-Meier Estimate<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Niacinamide--administration & dosage<br/>Odds Ratio<br/>Phenylurea Compounds--administration & dosage<br/>Protein Kinase Inhibitors--administration & dosage<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Risk Factors<br/>Sorafenib<br/>Treatment Outcome